Pharmaceuticals Market Research Reports & Industry Analysis

... on China’s sales operations and tactics. FirstWord’s new report sheds light on how Pharma is using its still-expanding Chinese sales force, with exclusive insights from sales managers at multinational and domestic companies China’s economy is one ...

... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs” is a unique study designed ...

... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices” is a unique study designed to help current suppliers and potential market entrants ...

... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Italy: Hospitals and Commercial Labs” is a unique study designed ...

... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Japan: Hospitals and Commercial Labs” is a unique study designed ...

... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers” is a unique study designed to help current suppliers and potential market entrants ...

... resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace ... , such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs” is a unique study ...

... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices” is a unique study designed to help current suppliers and potential market ...

... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique study designed to help current suppliers ...

... Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused ... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in the US: Hospitals, Commercial Labs, Physician Offices, ...

... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...

... Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused ... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Germany: Hospitals, Commercial Labs, Physician Offices” is a unique ...

... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...

... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Japan: Hospitals and Commercial Labs” is a unique market and ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...

... preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers” ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors. ...

... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in the UK: Hospitals and Commercial Labs” is a unique ... responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors ...

... Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused ... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market in the US: Hospitals, Commercial Labs, Physician Offices” ...

The Competitive Intelligence Report Anthrax Vaccines & Therapeutics as of June 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics for prophylaxis of Bacillus anthracis infection and treatment of anthrax. Purchase of the pdf report includes a 6-month online ...

... Group contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory ... . Five-year test volume and reagent sales forecasts for drugs of abuse procedures by market segment: Physician Offices/Group Practices Emergency ...

... brand images. Compared with that of countries with advanced medicine levels, China OTC drug industry is featured by late start, fast growth and ... or occupy market by regional advantages. With the standardizing development of domestic OTC drug market and the increase in residents' healthcare consciousness, the ...

Infinity (INFI) shares down on concerns that IPI-145 (PI3K-delta, ... detail, please read our report released on May 28, 2013, titled, “ASCO ‘13 to Reinstate Faith in IPI-145!”

... perspective on the actual market situation, trends and future outlook for vaccines in Ireland. The study provides essential market information for decision- ... market study answers to questions such as: What is the size of the vaccine market in Ireland? How is the market divided into different types of products ...

... perspective on the actual market situation, trends and future outlook for vaccines in Panama. The study provides essential market information for decision- ... market study answers to questions such as: What is the size of the vaccine market in Panama? How is the market divided into different types of products? ...

... as: What is the size of the vaccine markets in different countries around the world? How are the markets divided into different types ... Years covered: 2006 - 2017 Countries included in the package: Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Bolivia, Bulgaria, Canada, Chile, ...

... a perspective on the actual market situation, trends and future outlook for vaccines in Mongolia. The study provides essential market information for decision- ... study answers to questions such as: What is the size of the vaccine market in Mongolia? How is the market divided into different types of products? ...

... a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market ... These market studies answer to questions such as: What is the size of the vaccine markets in top 10 global countries? How are the markets divided into ...

... indicators This market study answers to questions such as: What is the size of the global vaccine market? How is the market divided into different types of products? Which products are growing fast? How the market has been developing? How does the future look like? What is the ...

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different American countries. The studies ... different types of products? Which products are growing fast? How the markets have been developing? How does the future look like? ...

... shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for ... , such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan” ...

... shares) $5,500. This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic ... as specimen preparation devices, controls, calibrators and others. “2013 Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan” ...

... as extensive listings of companies developing and marketing innovative technologies and products. This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new ...

... cheaper cost of trials, which are currently driving the market, it is expected that by 2016, the clinical trials market would surpass US$ 300 million mark. “Russia Clinical Trial Market Opportunity Analysis” research report by KuicK Research is an intriguing text that gives detailed facts and analysis on latest developments in the Russia Clinical Trial Market. Report ...

The Competitive Intelligence Report Human Papilloma Virus (HPV) Vaccines & Therapeutics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines of novel vaccines and therapeutics for prophylaxis of HPV infection and HPV-induced neoplasias and treatment of HPV-induced ...

... and operating incomes amidst patent cliffs of blockbuster drugs. In such a scenario, vaccines, which have high entry barriers for generic players and ... with high incidence rates of infectious diseases. The report, “Global Vaccine Market Forecast to 2017” provides an extensive research and in-depth analysis ...

... their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for drugs of ... Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive Assessments Assessments of major POC suppliers and ...

... to operate and provide facilities. It is expected that this business model of single clinics specialized in particular domain would lead the growth in the Indian healthcare industry. “India Specialty Clinics Market Outlook to 2016” research report by KuicK Research is an intriguing text that ...

... acquisition of Pharmasset in 2011 and ABBV through its alliance with Enanta (ENTA) in 2006. Gilead’s Sofosbuvir (PhIII, PMI) in combination with RBV ... our initiation report released on 17th April, 2013 on ENTA titled “Debut of a Star- 2nd in the Oral IFN free HCV Drug Race ...

... global management consulting and market research firm, has conducted a competitive analysis of the industry and presents its findings in Global Human Vaccine Industry 2013-2018: Trend, Profit, and Forecast Analysis. North America dominates this industry. India and China are rapidly growing as vaccine production ...

... impact of the economic downturn in Europe and the United States, China’s future vitamin market will face grim situation, especially exports even ... also with average export prices lifted to varying degrees . China Vitamin Industry Report, 2012-2015 of ResearchInChina mainly covers the followings: International ...

Product description The present Competitive Intelligence Report about Antibody-Drug Conjugates (ADC) / Immunoconjugates provides a competitor evaluation in the field of tumor targeting antibodies conjugated via a linker with a drug payload for treatment of cancer as of April 2013. Purchase of the ...

Product description The Competitive Intelligence Report Insulin as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant insulin and in...

Product description The Competitive Intelligence Report Interferon as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant and natural...

How do antibody characteristics impact clinical success? The analytical report 'Influence of Antibody Attributes on Clinical Success – A Technology and Coporate Benchmark Analysis' evaluates the impact of a number of antibody attributes on the success rate of antibodies in clinical development. Among ...

... in 2018. Lucintel, a leading global management consulting and market research firm, has analyzed the global oncology drugs industry and presents its findings in Global Oncology Drugs Industry 2013-2018: Trend, Profit, and Forecast Analysis. The industry comprises firms primarily engaged in the development, manufacture, and marketing of oncology drugs. Lucintels ...

... Five Global Generic Drug Companies Performance, Strategies, and Competitive Analysis. The report provides detailed insight into the performance of the top five generic drug companies ... the market share for generic drugs. This study provides industry leaders with a competitive benchmarking of the worlds top five generic drug companies. The study ...

... extensive analysis from experts in many fields to predict the top 10 Pharma companies in 2017. To stay ahead of your competition, you need to have the ... fingertips. Download this powerful report today. Each of the top 10 pharma companies for 2017 has its own report, providing an overall sales ... for the ten pharma companies that are expected to lead the market in 2017 Analyst consensus sales forecasts for each company’s top five ...

Benign prostatic hyperplasia (BPH) is a common disease among middle-aged and elderly men, with an increasing morbidity as the rise in ages. Its invasion ... patent drug manufacturers. Meanwhile, it is also a huge market. Therefore, the prospect of China’s anti-PH drug market is very bright. The annual growth rate ...

This report provides: Worldwide overview of the laboratory and POC hemostasis testing markets Estimates of facilities performing hemostasis tests Test volume and sales forecasts for hemostasis reagents and instruments by country Major suppliers' sales and market shares. Contains 18 pages and 8 tables

... and mHealth developers themselves. Whether your company is looking to expand into mHealth apps or seeking sound advice on a way forward, Pharma and the mHealth Revolution - engaging ... from pharma in developing mHealth apps for healthcare providers Detailed insight into five major pharma mHealth projects Methodologies for determining the platforms on which mHealth ...

... test that all antisense/ RNAi focused companies have to pass. ISIS has a robust cash position, valuable IP assets, and success of a few ... in the current pipeline could accelerate the transformation from a discovery to a pharma company and help it to grow beyond KYNAMRO.